Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phyo Than Htoo, Ph.D.

Concepts (75)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dipeptidyl-Peptidase IV Inhibitors220232931.380 Why?
Benzhydryl Compounds220248451.210 Why?
Diabetes Mellitus, Type 282024117260.930 Why?
Glucosides220244510.890 Why?
Atherosclerosis3202434440.850 Why?
Hypoglycemic Agents8202428730.750 Why?
Cardiovascular Diseases72024151600.700 Why?
Renal Insufficiency, Chronic2202322000.670 Why?
Hypoglycemia120238610.560 Why?
Heart Failure42024108950.500 Why?
Angiotensin Receptor Antagonists120199230.460 Why?
Angiotensin-Converting Enzyme Inhibitors1201915160.430 Why?
Influenza, Human1202214790.380 Why?
Pneumonia1202221330.360 Why?
Sulfonylurea Compounds220232050.340 Why?
Glucose5202343980.320 Why?
Colorectal Neoplasms2201967730.310 Why?
Medicare5202465660.300 Why?
Sodium3202216220.210 Why?
Myocardial Infarction22022117180.210 Why?
Stroke2202499810.200 Why?
Oseltamivir12022750.200 Why?
Electronics120223220.180 Why?
Sodium Chloride Symporter Inhibitors12019760.170 Why?
Hypertension1201984790.170 Why?
United States82024698720.170 Why?
Diabetes Mellitus1201657490.150 Why?
Calcium Channel Blockers120196920.140 Why?
Aged920241632880.140 Why?
Cohort Studies62023405590.120 Why?
Adrenergic beta-Antagonists1201912400.120 Why?
Thiazolidinediones120164760.110 Why?
Vulnerable Populations120176860.100 Why?
Analgesia, Epidural120143260.100 Why?
Antihypertensive Agents1201920470.090 Why?
Proportional Hazards Models32019123560.090 Why?
Incidence22019209520.090 Why?
Antiviral Agents1202229870.090 Why?
Humans1420247443660.090 Why?
Insulin1202365820.080 Why?
Chemotherapy, Adjuvant1201734800.080 Why?
Randomized Controlled Trials as Topic1202399550.070 Why?
Aged, 80 and over42019577760.070 Why?
Hospitalization22022102590.070 Why?
Retrospective Studies32022774600.060 Why?
Adolescent22024857790.060 Why?
Stomach Neoplasms1201413320.060 Why?
Pain, Postoperative1201416430.060 Why?
Medicaid1201727370.060 Why?
Anti-Bacterial Agents1202271820.060 Why?
Early Detection of Cancer1201730860.060 Why?
Matched-Pair Analysis120212880.050 Why?
SEER Program2201715070.050 Why?
Female720223801930.050 Why?
Breast Neoplasms22017208240.040 Why?
Male520223501150.040 Why?
Ohio120173370.040 Why?
Epidemiologic Studies120196760.030 Why?
Antineoplastic Agents12017136930.030 Why?
Neoplasm Staging22017110310.030 Why?
Information Storage and Retrieval120178240.020 Why?
Age of Onset1201732700.020 Why?
Adult220222140520.020 Why?
Population Surveillance1201726160.020 Why?
Poverty1201726600.020 Why?
Odds Ratio1201798490.020 Why?
Comorbidity12017103880.010 Why?
Databases, Factual1201777300.010 Why?
Case-Control Studies12017217480.010 Why?
Logistic Models12014134090.010 Why?
Time Factors12019400750.010 Why?
Neoplasm Recurrence, Local1201492400.010 Why?
Middle Aged220212133900.010 Why?
Risk Factors12017722960.010 Why?
Treatment Outcome12014631070.000 Why?
Htoo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (75)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.